![](/img/cover-not-exists.png)
Novel mutations in the reverse transcriptase of HIV-1 reduce susceptibility to phosphonoformate in laboratory and clinical isolates: J. Mellors1, H. Bazmi1, R. Schinazi2, B. Roy3, Y. Hsiov3, E. Arnold3, J. Weir4, D. Mayers4. 1University of Pittsburgh/VAMC, Pittsburgh, PA, 2Emory University/VAMC, Decatur, GA, 3Rutgers University/CAMB, Piscataway, NJ, 4Military Medicine Consortium for Applied Retroviral Research, Rockville, MD, USA
Volume:
26
Year:
1995
Language:
english
Pages:
1
DOI:
10.1016/0166-3542(95)94718-h
File:
PDF, 73 KB
english, 1995